Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 89

1.

New Avenues for Antimicrobial Stewardship: The Case for Penicillin Skin Testing by Pharmacists.

Cheon E, Horowitz HW.

Clin Infect Dis. 2019 May 30;68(12):2123-2124. doi: 10.1093/cid/ciy828.

PMID:
30281071
2.

Infection control IV: Moving forward- infection preventionists' scope of practice.

Horowitz HW.

Am J Infect Control. 2018 Jul;46(7):734-735. doi: 10.1016/j.ajic.2018.02.030. Epub 2018 May 2. No abstract available.

PMID:
29729831
3.

Reconsidering Treatment of Community-Acquired Pneumonia: Are Macrolides Plus β-Lactams Essential?

Horowitz HW.

Clin Infect Dis. 2018 Jul 18;67(3):481-482. doi: 10.1093/cid/ciy123. No abstract available.

PMID:
29438523
4.

To Assess the Success of Computerized Order Sets and Pharmacy Education Modules in Improving Antiretroviral Prescribing.

Mehta D, Kohn B, Blumenfeld M, Horowitz HW.

J Pharm Pract. 2018 Oct;31(5):450-456. doi: 10.1177/0897190017729599. Epub 2017 Sep 7.

PMID:
28877642
5.

Infection control III: Infection prevention and control as mediators.

Horowitz HW.

Am J Infect Control. 2017 May 1;45(5):519-520. doi: 10.1016/j.ajic.2017.01.034. Epub 2017 Mar 7. No abstract available.

PMID:
28283203
6.

Errors in isolation of patients with infectious tuberculosis at a public teaching hospital in New York.

Bhatraju P, Patrawalla P, Trieu L, Ahuja SD, Marchione S, Douyon F, Horowitz HW, Leibert E.

Int J Tuberc Lung Dis. 2016 Sep;20(9):1168-73. doi: 10.5588/ijtld.15.0808.

PMID:
27510241
7.

Infection control II: A practical guide to getting to zero.

Horowitz HW.

Am J Infect Control. 2016 Sep 1;44(9):1075-7. doi: 10.1016/j.ajic.2016.02.032. Epub 2016 May 5. No abstract available.

PMID:
27158090
8.

Are Mandatory Electronic Prescriptions in the Best Interest of Patients?

Wormser GP, Erb M, Horowitz HW.

Am J Med. 2016 Mar;129(3):233-4. doi: 10.1016/j.amjmed.2015.10.036. Epub 2015 Nov 14. No abstract available.

PMID:
26584970
9.

Infection control: Public reporting, disincentives, and bad behavior.

Horowitz HW.

Am J Infect Control. 2015 Sep 1;43(9):989-91. doi: 10.1016/j.ajic.2015.02.033. Epub 2015 Jun 24. No abstract available.

PMID:
26116332
10.

Fever of unknown origin or fever of too many origins?

Horowitz HW.

N Engl J Med. 2013 Jan 17;368(3):197-9. doi: 10.1056/NEJMp1212725. No abstract available.

PMID:
23323894
11.

Differences and similarities between culture-confirmed human granulocytic anaplasmosis and early lyme disease.

Wormser GP, Aguero-Rosenfeld ME, Cox ME, Nowakowski J, Nadelman RB, Holmgren D, McKenna D, Bittker S, Zentmaier L, Cooper D, Liveris D, Schwartz I, Horowitz HW.

J Clin Microbiol. 2013 Mar;51(3):954-8. doi: 10.1128/JCM.02929-12. Epub 2013 Jan 9.

12.

Giant PPD reaction with positive QuantiFERON-TB Gold in a patient with lepromatous leprosy.

Murthy V, Horowitz HW, Pham VP, Levis WR.

J Drugs Dermatol. 2012 Oct;11(10):1151-2. No abstract available.

PMID:
23285712
13.

Lyme disease and human granulocytic anaplasmosis coinfection: impact of case definition on coinfection rates and illness severity.

Horowitz HW, Aguero-Rosenfeld ME, Holmgren D, McKenna D, Schwartz I, Cox ME, Wormser GP.

Clin Infect Dis. 2013 Jan;56(1):93-9. doi: 10.1093/cid/cis852. Epub 2012 Oct 5.

PMID:
23042964
14.

Vertical transmission of Babesia microti, United States.

Joseph JT, Purtill K, Wong SJ, Munoz J, Teal A, Madison-Antenucci S, Horowitz HW, Aguero-Rosenfeld ME, Moore JM, Abramowsky C, Wormser GP.

Emerg Infect Dis. 2012 Aug;18(8):1318-21. doi: 10.3201/eid1808.110988.

15.

Epidemiology and burden of hepatitis A, malaria, and typhoid in New York City associated with travel: implications for public health policy.

Adamson R, Reddy V, Jones L, Antwi M, Bregman B, Weiss D, Phillips M, Horowitz HW.

Am J Public Health. 2010 Jul;100(7):1249-52. doi: 10.2105/AJPH.2009.178335. Epub 2010 May 13.

16.

Expanding the horizons of histoplasmosis: disseminated histoplasmosis in a renal transplant patient after a trip to Bangladesh.

Rappo U, Beitler JR, Faulhaber JR, Firoz B, Henning JS, Thomas KM, Maslow M, Goldfarb DS, Horowitz HW.

Transpl Infect Dis. 2010 Apr;12(2):155-60. doi: 10.1111/j.1399-3062.2009.00466.x. Epub 2009 Oct 29.

PMID:
19878490
17.

A piece of my mind. The interpreter of facts.

Horowitz HW.

JAMA. 2008 Feb 6;299(5):497-8. doi: 10.1001/jama.299.5.497. No abstract available.

PMID:
18252874
18.

Prevalence of drug-resistant and nonsubtype B HIV strains in antiretroviral-naïve, HIV-infected individuals in New York State.

Parker MM, Gordon D, Reilly A, Horowitz HW, Waters M, Bennett R, Hallack R, Smith J, Lamson D, Aydemir A, Dvali N, Agins BD, Drusano GL, Taylor J; Resistance Study Group.

AIDS Patient Care STDS. 2007 Sep;21(9):644-52.

PMID:
17919091
19.

Human granulocytic anaplasmosis during pregnancy: case series and literature review.

Dhand A, Nadelman RB, Aguero-Rosenfeld M, Haddad FA, Stokes DP, Horowitz HW.

Clin Infect Dis. 2007 Sep 1;45(5):589-93. Epub 2007 Jul 30. Review.

PMID:
17682993
20.

Intravascular device infections: epidemiology, diagnosis, and management.

Gandelman G, Frishman WH, Wiese C, Green-Gastwirth V, Hong S, Aronow WS, Horowitz HW.

Cardiol Rev. 2007 Jan-Feb;15(1):13-23. Review.

PMID:
17172879
21.

Once-daily versus twice-daily lopinavir/ritonavir in antiretroviral-naive HIV-positive patients: a 48-week randomized clinical trial.

Eron JJ, Feinberg J, Kessler HA, Horowitz HW, Witt MD, Carpio FF, Wheeler DA, Ruane P, Mildvan D, Yangco BG, Bertz R, Bernstein B, King MS, Sun E.

J Infect Dis. 2004 Jan 15;189(2):265-72. Epub 2004 Jan 7.

PMID:
14722892
22.

Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States.

Ostrosky-Zeichner L, Rex JH, Pappas PG, Hamill RJ, Larsen RA, Horowitz HW, Powderly WG, Hyslop N, Kauffman CA, Cleary J, Mangino JE, Lee J.

Antimicrob Agents Chemother. 2003 Oct;47(10):3149-54.

23.

A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients.

Pappas PG, Rex JH, Lee J, Hamill RJ, Larsen RA, Powderly W, Kauffman CA, Hyslop N, Mangino JE, Chapman S, Horowitz HW, Edwards JE, Dismukes WE; NIAID Mycoses Study Group.

Clin Infect Dis. 2003 Sep 1;37(5):634-43. Epub 2003 Aug 14.

PMID:
12942393
24.

A randomized and blinded multicenter trial of high-dose fluconazole plus placebo versus fluconazole plus amphotericin B as therapy for candidemia and its consequences in nonneutropenic subjects.

Rex JH, Pappas PG, Karchmer AW, Sobel J, Edwards JE, Hadley S, Brass C, Vazquez JA, Chapman SW, Horowitz HW, Zervos M, McKinsey D, Lee J, Babinchak T, Bradsher RW, Cleary JD, Cohen DM, Danziger L, Goldman M, Goodman J, Hilton E, Hyslop NE, Kett DH, Lutz J, Rubin RH, Scheld WM, Schuster M, Simmons B, Stein DK, Washburn RG, Mautner L, Chu TC, Panzer H, Rosenstein RB, Booth J; National Institute of Allergy and Infectious Diseases Mycoses Study Group.

Clin Infect Dis. 2003 May 15;36(10):1221-8. Epub 2003 May 8.

PMID:
12746765
25.

A piece of my mind. Dumbing down.

Horowitz HW.

JAMA. 2003 Mar 19;289(11):1349-50. No abstract available.

PMID:
12636437
26.

A piece of my mind. The three-legged stool.

Horowitz HW.

JAMA. 2002 Sep 18;288(11):1327. No abstract available.

PMID:
12234212
27.

Analysis of sequences and loci of p44 homologs expressed by Anaplasma phagocytophila in acutely infected patients.

Lin Q, Zhi N, Ohashi N, Horowitz HW, Aguero-Rosenfeld ME, Raffalli J, Wormser GP, Rikihisa Y.

J Clin Microbiol. 2002 Aug;40(8):2981-8.

28.

Western blot analysis of sera reactive to human monocytic ehrlichiosis and human granulocytic ehrlichiosis agents.

Unver A, Felek S, Paddock CD, Zhi N, Horowitz HW, Wormser GP, Cullman LC, Rikihisa Y.

J Clin Microbiol. 2001 Nov;39(11):3982-6.

29.

Dexamethasone inhibits CD4 T cell deletion mediated by macrophages from human immunodeficiency virus-infected persons.

Orlikowsky TW, Wang ZQ, Dudhane A, Dannecker GE, Niethammer D, Wormser GP, Hoffmann MK, Horowitz HW.

J Infect Dis. 2001 Nov 15;184(10):1328-30. Epub 2001 Oct 2.

PMID:
11679924
30.

Costs and savings associated with infection control measures that reduced transmission of vancomycin-resistant enterococci in an endemic setting.

Montecalvo MA, Jarvis WR, Uman J, Shay DK, Petrullo C, Horowitz HW, Wormser GP.

Infect Control Hosp Epidemiol. 2001 Jul;22(7):437-42.

PMID:
11583213
31.

Serial measurements of hematologic counts during the active phase of human granulocytic ehrlichiosis.

Bakken JS, Aguero-Rosenfeld ME, Tilden RL, Wormser GP, Horowitz HW, Raffalli JT, Baluch M, Riddell D, Walls JJ, Dumler JS.

Clin Infect Dis. 2001 Mar 15;32(6):862-70. Epub 2001 Mar 7.

PMID:
11247709
32.

Antimicrobial susceptibility of Ehrlichia phagocytophila.

Horowitz HW, Hsieh TC, Aguero-Rosenfeld ME, Kalantarpour F, Chowdhury I, Wormser GP, Wu JM.

Antimicrob Agents Chemother. 2001 Mar;45(3):786-8.

33.

Risk of hepatitis E infection to travelers.

Piper-Jenks N, Horowitz HW, Schwartz E.

J Travel Med. 2000 Jul-Aug;7(4):194-9. Review.

34.

Comparison of two recombinant major outer membrane proteins of the human granulocytic ehrlichiosis agent for use in an enzyme-linked immunosorbent assay.

Tajima T, Zhi N, Lin Q, Rikihisa Y, Horowitz HW, Ralfalli J, Wormser GP, Hechemy KE.

Clin Diagn Lab Immunol. 2000 Jul;7(4):652-7.

35.

Adherence to prescription medications among medical professionals.

Corda RS, Burke HB, Horowitz HW.

South Med J. 2000 Jun;93(6):585-9.

PMID:
10881774
36.

Serology of culture-confirmed cases of human granulocytic ehrlichiosis.

Aguero-Rosenfeld ME, Kalantarpour F, Baluch M, Horowitz HW, McKenna DF, Raffalli JT, Hsieh Tc, Wu J, Dumler JS, Wormser GP.

J Clin Microbiol. 2000 Feb;38(2):635-8.

37.

Laboratory methods of diagnosis of syphilis for the beginning of the third millennium.

Wicher K, Horowitz HW, Wicher V.

Microbes Infect. 1999 Oct;1(12):1035-49. Review.

PMID:
10617935
38.

Thrombocytopenia and Borrelia burgdorferi: an association remains unproven.

Nadelman RB, Nowakowski J, Horowitz HW, Strle F, Wormser GP.

Clin Infect Dis. 1999 Dec;29(6):1603-5. No abstract available.

PMID:
10585841
39.

Millennial child: intern's admission note, November 17, 2150.

Horowitz HW.

JAMA. 1999 Nov 17;282(19):1799. No abstract available.

PMID:
10573257
40.

Polyspecific self-reactive antibodies in individuals infected with human immunodeficiency virus facilitate T cell deletion and inhibit costimulatory accessory cell function.

Wang Zq, Horowitz HW, Orlikowsky T, Hahn BI, Trejo V, Bapat AS, Mittler RS, Rayanade RJ, Yang SY, Hoffmann MK.

J Infect Dis. 1999 Oct;180(4):1072-9.

PMID:
10479133
41.

Infection-control measures reduce transmission of vancomycin-resistant enterococci in an endemic setting.

Montecalvo MA, Jarvis WR, Uman J, Shay DK, Petrullo C, Rodney K, Gedris C, Horowitz HW, Wormser GP.

Ann Intern Med. 1999 Aug 17;131(4):269-72.

PMID:
10454948
42.

Concomitant human immunodeficiency virus protease inhibitor therapy markedly reduces tacrolimus metabolism and increases blood levels.

Sheikh AM, Wolf DC, Lebovics E, Goldberg R, Horowitz HW.

Transplantation. 1999 Jul 27;68(2):307-9.

PMID:
10440408
43.

Clinical and laboratory evolution of a culture-confirmed case of human granulocytic ehrlichiosis.

Hossain D, Aguero-Rosenfeld ME, Horowitz HW, Wu JM, Hsieh TC, Sachdeva N, Peterson SJ, Dumler JS, Wormser GP.

Conn Med. 1999 May;63(5):265-70.

PMID:
10363404
44.

Atovaquone compared with dapsone to prevent Pneumocystis carinii pneumonia.

Horowitz HW, Wormser GP.

N Engl J Med. 1999 May 13;340(19):1512-3. No abstract available.

PMID:
10328722
45.

Changes in expression of the 44-kilodalton outer surface membrane antigen (p44 kD) for monitoring progression of infection and antimicrobial susceptibility of the human granulocytic ehrlichiosis (HGE) agent in HL-60 cells.

Hsieh T, DiPietrantonio AM, Horowitz HW, Dumler JS, Aguero-Rosenfeld ME, Wormser GP, Wu JM.

Biochem Biophys Res Commun. 1999 Apr 13;257(2):351-5.

PMID:
10198216
46.

Human immunodeficiency virus infection, Part II.

Horowitz HW, Telzak EE, Sepkowitz KA, Wormser GP.

Dis Mon. 1998 Dec;44(12):677-716. Review.

PMID:
9883269
47.

Clinical and laboratory spectrum of culture-proven human granulocytic ehrlichiosis: comparison with culture-negative cases.

Horowitz HW, Aguero-Rosenfeld ME, McKenna DF, Holmgren D, Hsieh TC, Varde SA, Dumler SJ, Wu JM, Schwartz I, Rikihisa Y, Wormser GP.

Clin Infect Dis. 1998 Nov;27(5):1314-7.

PMID:
9827289
48.

Human immunodeficiency virus infection, Part I.

Horowitz HW, Telzak EE, Sepkowitz KA, Wormser GP.

Dis Mon. 1998 Oct;44(10):545-606. Review.

PMID:
9814367
49.

Reinfection with the agent of human granulocytic ehrlichiosis.

Horowitz HW, Aguero-Rosenfeld M, Dumler JS, McKenna DF, Hsieh TC, Wu J, Schwartz I, Wormser GP.

Ann Intern Med. 1998 Sep 15;129(6):461-3. No abstract available.

PMID:
9735084
50.

A piece of my mind. Hey! I'm a teacher too.

Horowitz HW.

JAMA. 1998 Sep 2;280(9):765. No abstract available.

PMID:
9729985

Supplemental Content

Loading ...
Support Center